Pandemics such as COVID-19 require investments for additional manpower, equipment, consumables, and other resources to ensure 100% preparedness for safety in hospitals and, if needed, eventual treatment of patients. The COVID-19 pandemic is an accelerator for AI technology by creating opportunities for leveraging these tools …
The global embolotherapy market is valued at USD 3.4 billion in 2021 and is expected to reach USD 5.0 billion by 2026, at a CAGR of 8.0% during the forecast period. Increasing incidences of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids coupled with …
The osteoarthritis therapeutics market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025. The presence of a large geriatric and target patient population and the improving healthcare infrastructure in several …
The global influenza diagnostic market is projected to reach USD 1,012 million in 2025 from USD 695 million in 2020, at a CAGR of 7.8% during the forecast period. Market growth is largely driven by factors such as the increasing prevalence of influenza, growth in …
The veterinary software market to grow from USD 442 million in 2017 to USD 594 million by 2022, at a CAGR of 6.1% during the forecast period.
The benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 billion in 2021, at a CAGR of 5.3% from 2021 to 2026. The presence of a large geriatric and target patient population and the improving healthcare infrastructure …
Neuroprostheses uses electrodes to interface with the central or peripheral nervous system to restore lost motor or sensory capabilities. These devices can receive neural signals from the external environment & brain, and convert the signals to restore functions such as loss of hearing and vision. …
The global mice model market size is projected to reach USD 1.9 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.4% during the forecast period. Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing implications of mouse clinical trials …
The neurodiagnostics market is expected to reach USD 8.4 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 7.3%. The demand for neurodiagnostics products is expected to grow mainly due to factors such as the increasing prevalence of neurological disorders & …
The airway management devices market is projected to reach USD 2.0 billion by 2024 from USD 1.6 billion in 2019, at a CAGR of 5.1%. The growth of the market is driven mainly by the rising prevalence of chronic respiratory diseases; increasing demand for emergency …
The global surgical sealants and adhesives market is expected to reach USD 2.8 billion in 2025 from USD 1.9 billion in 2020, at a CAGR of 8.4% during the forecast period. Growth in this market is driven by the growing prevalence and incidence rates of …
The global capnography equipment market is projected to reach USD 366.5 million by 2023 from USD 297.1 million in 2018, at a CAGR of 4.3%. Factors such as the development of portable/point-of-care capnography devices, clinical benefits of capnography equipment over pulse oximetry, increasing number of …
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency and …
The osteoarthritis therapeutics market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025. The presence of a large geriatric and target patient population and the improving healthcare infrastructure in several …